Nutrien (0NHS) Ratios
Nutrien Ratios
GB:0NHS's free cash flow for Q2 2026 was $1.95B. For the 2026 fiscal year, GB:0NHS's free cash flow was decreased by $-456.08M and operating cash flow was $2.40B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.34 | 1.15 | 1.17 | 1.14 | 1.11 |
| Quick Ratio | 0.70 | 0.63 | 0.65 | 0.61 | 0.60 |
| Cash Ratio | 0.06 | 0.07 | 0.08 | 0.06 | 0.04 |
| Solvency Ratio | 0.17 | 0.11 | 0.12 | 0.34 | 0.19 |
| Operating Cash Flow Ratio | 0.37 | 0.29 | 0.42 | 0.57 | 0.31 |
| Short-Term Operating Cash Flow Coverage | 2.94 | 1.37 | 2.18 | 3.02 | 1.85 |
| Net Current Asset Value | $ -12.16B | $ -13.61B | $ -13.38B | $ -12.38B | $ -12.41B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.25 | 0.24 | 0.22 | 0.22 |
| Debt-to-Equity Ratio | 0.48 | 0.52 | 0.50 | 0.46 | 0.46 |
| Debt-to-Capital Ratio | 0.32 | 0.34 | 0.33 | 0.32 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.27 | 0.27 | 0.26 | 0.24 | 0.24 |
| Financial Leverage Ratio | 2.07 | 2.12 | 2.10 | 2.11 | 2.11 |
| Debt Service Coverage Ratio | 2.52 | 1.14 | 1.36 | 3.22 | 2.16 |
| Interest Coverage Ratio | 5.22 | 4.00 | 5.05 | 21.97 | 9.80 |
| Debt to Market Cap | 0.36 | 0.52 | 0.40 | 0.27 | 0.22 |
| Interest Debt Per Share | 26.15 | 27.38 | 26.81 | 23.07 | 19.90 |
| Net Debt to EBITDA | 1.88 | 2.84 | 2.38 | 0.86 | 1.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.05% | 28.99% | 29.16% | 40.71% | 33.95% |
| EBIT Margin | 13.57% | 7.21% | 9.35% | 28.42% | 16.71% |
| EBITDA Margin | 22.38% | 16.22% | 16.81% | 33.73% | 23.75% |
| Operating Profit Margin | 13.57% | 11.36% | 13.28% | 28.53% | 17.25% |
| Pretax Profit Margin | 11.54% | 4.37% | 6.72% | 27.05% | 15.04% |
| Net Profit Margin | 8.58% | 2.60% | 4.33% | 20.22% | 11.38% |
| Continuous Operations Profit Margin | 8.69% | 2.70% | 4.41% | 20.29% | 11.47% |
| Net Income Per EBT | 74.35% | 59.33% | 64.45% | 74.76% | 75.65% |
| EBT Per EBIT | 85.03% | 38.50% | 50.57% | 94.79% | 87.18% |
| Return on Assets (ROA) | 4.42% | 1.30% | 2.38% | 14.03% | 6.31% |
| Return on Equity (ROE) | 9.13% | 2.76% | 5.00% | 29.67% | 13.33% |
| Return on Capital Employed (ROCE) | 8.86% | 7.42% | 9.50% | 26.82% | 12.75% |
| Return on Invested Capital (ROIC) | 6.41% | 4.26% | 5.86% | 18.73% | 9.14% |
| Return on Tangible Assets | 6.00% | 1.77% | 3.27% | 19.19% | 8.91% |
| Earnings Yield | 7.69% | 3.05% | 4.50% | 19.51% | 7.36% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.75 | 4.82 | 5.38 | 6.12 | 5.16 |
| Payables Turnover | 2.00 | 3.44 | 3.58 | 3.87 | 3.53 |
| Inventory Turnover | 2.66 | 3.00 | 3.09 | 2.94 | 2.89 |
| Fixed Asset Turnover | 1.18 | 1.15 | 1.29 | 1.74 | 1.38 |
| Asset Turnover | 0.51 | 0.50 | 0.55 | 0.69 | 0.55 |
| Working Capital Turnover Ratio | 9.87 | 13.68 | 14.14 | 21.87 | 12.62 |
| Cash Conversion Cycle | 31.07 | 91.36 | 83.80 | 89.50 | 93.59 |
| Days of Sales Outstanding | 76.91 | 75.75 | 67.81 | 59.68 | 70.68 |
| Days of Inventory Outstanding | 137.12 | 121.68 | 117.94 | 124.03 | 126.19 |
| Days of Payables Outstanding | 182.95 | 106.06 | 101.95 | 94.21 | 103.28 |
| Operating Cycle | 214.03 | 197.43 | 185.75 | 183.71 | 196.87 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.38 | 7.15 | 10.19 | 15.06 | 6.82 |
| Free Cash Flow Per Share | 4.19 | 2.79 | 4.96 | 10.53 | 3.69 |
| Dividend Paid and CapEx Coverage Ratio | 1.31 | 1.10 | 1.37 | 2.34 | 1.37 |
| Capital Expenditure Coverage Ratio | 2.00 | 1.64 | 1.90 | 3.33 | 2.18 |
| Operating Cash Flow Coverage Ratio | 0.34 | 0.28 | 0.40 | 0.68 | 0.36 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.14 | 0.17 | 0.21 | 0.14 |
| Free Cash Flow Yield | 6.79% | 6.25% | 8.81% | 14.44% | 4.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.02 | 32.86 | 22.24 | 5.13 | 13.58 |
| Price-to-Sales (P/S) Ratio | 1.12 | 0.85 | 0.96 | 1.04 | 1.55 |
| Price-to-Book (P/B) Ratio | 1.19 | 0.91 | 1.11 | 1.52 | 1.81 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.73 | 16.01 | 11.35 | 6.92 | 20.36 |
| Price-to-Operating Cash Flow Ratio | 7.36 | 6.25 | 5.52 | 4.84 | 11.02 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | -0.71 | -0.27 | 0.03 | 0.02 |
| Enterprise Value Multiple | 6.87 | 8.09 | 8.11 | 3.94 | 8.08 |
| Enterprise Value | 41.32B | 34.06B | 39.61B | 50.29B | 53.17B |
| EV to EBITDA | 6.87 | 8.09 | 8.11 | 3.94 | 8.08 |
| EV to Sales | 1.54 | 1.31 | 1.36 | 1.33 | 1.92 |
| EV to Free Cash Flow | 20.29 | 24.67 | 16.06 | 8.87 | 25.28 |
| EV to Operating Cash Flow | 10.14 | 9.64 | 7.82 | 6.20 | 13.68 |
| Tangible Book Value Per Share | 23.73 | 21.39 | 21.86 | 20.80 | 16.04 |
| Shareholders’ Equity Per Share | 51.97 | 49.34 | 50.59 | 47.95 | 41.52 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.38 | 0.34 | 0.25 | 0.24 |
| Revenue Per Share | 55.28 | 52.51 | 58.44 | 70.35 | 48.65 |
| Net Income Per Share | 4.74 | 1.36 | 2.53 | 14.23 | 5.53 |
| Tax Burden | 0.74 | 0.59 | 0.64 | 0.75 | 0.76 |
| Interest Burden | 0.85 | 0.61 | 0.72 | 0.95 | 0.90 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.15 | 0.16 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | -0.00 | 0.00 | 0.01 |
| Income Quality | 1.77 | 5.05 | 4.03 | 1.06 | 1.22 |
Currency in USD